financetom
Business
financetom
/
Business
/
Nvidia, Apple Among Wedbush Securities' Top Stocks in AI Revolution
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia, Apple Among Wedbush Securities' Top Stocks in AI Revolution
Nov 25, 2025 8:31 AM

11:07 AM EST, 11/25/2025 (MT Newswires) -- Nvidia ( NVDA ) and Apple ( AAPL ) are among the top technology stocks to own into the year-end and as the artificial intelligence revolution unfolds, Wedbush Securities said in a Tuesday note.

The investment firm listed its top 10 AI stocks as it dismissed recent talk of an AI bubble.

"It is still very early days in the AI revolution as more enterprise customers and CIOs discover the role AI will play in their respective organizations and this is set to drive the next wave of massive AI strategic

deployments," Wedbush said, highlighting the early stages of autonomous, consumer AI, and robotics.

In its top 10 list, Wedbush said Nvidia's ( NVDA ) chips will fuel the AI revolution and Apple ( AAPL ) the consumer AI revolution. Also in the list are Microsoft ( MSFT ) as a hyperscaler for enterprise deployments and Alphabet (GOOG, GOOGL) for tailwinds from its Gemini models.

Price: 171.97, Change: -10.58, Percent Change: -5.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nordson to Buy Atrion for $460 per Share
Nordson to Buy Atrion for $460 per Share
May 28, 2024
07:37 AM EDT, 05/28/2024 (MT Newswires) -- Nordson ( NDSN ) said Tuesday it has agreed to buy Atrion ( ATRI ) for $460 per share in cash, representing an enterprise value of roughly $800 million. The company, which plans to finance the transaction through cash on hand and newly issued financial debt, said it expects deal completion before its...
Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment
Satellos Bioscience Forms Advisory Board to Advance SAT-3247 in Duchenne Muscular Dystrophy Treatment
May 28, 2024
07:37 AM EDT, 05/28/2024 (MT Newswires) -- Satellos Bioscience ( MSCLF ) on Tuesday said it has formed a clinical advisory board comprised of clinical research and drug development experts in genetic muscle disorders, including Duchenne muscular dystrophy. The formation of this clinical advisory board marks a major development step for Satellos as we continue our evolution in becoming a...
J&J acquires rights to skin disorder drug for $1.25 bln
J&J acquires rights to skin disorder drug for $1.25 bln
May 28, 2024
May 28 (Reuters) - Johnson & Johnson ( JNJ ) said on Tuesday that it had agreed to acquire the rights to an experimental skin disorder treatment from privately held Numab Therapeutics for about $1.25 billion. J&J will acquire Numab's unit for the global rights to the drug, called NM26. (Reporting by Christy Santhosh in Bengaluru; Editing by Anil D'Silva)...
T-Mobile to buy UScellular's wireless operations for $4.4 billion
T-Mobile to buy UScellular's wireless operations for $4.4 billion
May 28, 2024
May 28 (Reuters) - T-Mobile will buy substantially all of UScellular's wireless operations in a deal valued at $4.4 billion, the telecom giant said on Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved